Literature DB >> 20465419

Hepatoprotective role of bis-demethoxy curcumin analog on the expression of matrix metalloproteinase induced by alcohol and polyunsaturated fatty acid in rats.

Rukkumani Rajagopalan1, Subhashree Sridharana, Venugopal P Menon.   

Abstract

Liver fibrosis is one of the major health problems worldwide. Chronic alcohol abuse is one of the main causes of fibrosis. Ingestion of polyunsaturated fatty acids (PUFA) along with alcohol further aggravates the toxicity of alcohol. Fibrosis results due to increased deposition of extra cellular matrix (ECM). The degree of abnormal ECM degradation depends on the ratio of active matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs). The present work studied the influence of bis-desmethoxy curcumin analog (BDMC-A) on the expression of MMPs and TIMPs during alcohol and DeltaPUFA induced liver toxicity. Male albino Wistar rats were used for the study. The MMP expression was found to be increased in alcohol as well as DeltaPUFA treated rats and decreased in alcohol + DeltaPUFA treated rats. The levels of TIMPs and the collagen were increased in alcohol, DeltaPUFA, and alcohol + DeltaPUFA groups. Administration of BDMC-A significantly decreased the levels of collagen and TIMPs; and positively modulated the expression of MMPs. From this study, it is concluded that BDMC-A influences MMPs, TIMPs expression, and acts as an efficient anti-fibrotic agent.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20465419     DOI: 10.3109/15376516.2010.482961

Source DB:  PubMed          Journal:  Toxicol Mech Methods        ISSN: 1537-6516            Impact factor:   2.987


  4 in total

Review 1.  Curcumin targets multiple pathways to halt hepatic stellate cell activation: updated mechanisms in vitro and in vivo.

Authors:  Youcai Tang
Journal:  Dig Dis Sci       Date:  2014-12-23       Impact factor: 3.199

2.  Apoptosis induction by an analog of curcumin (BDMC-A) in human laryngeal carcinoma cells through intrinsic and extrinsic pathways.

Authors:  Kumaravel Mohankumar; Sankar Pajaniradje; Subhashree Sridharan; Vivek Kumar Singh; Larance Ronsard; Akhil C Banerjea; Benson Chellakkan Selvanesan; Mohane Selvaraj Coumar; Latha Periyasamy; Rukkumani Rajagopalan
Journal:  Cell Oncol (Dordr)       Date:  2014-12-01       Impact factor: 6.730

3.  Herbal products: benefits, limits, and applications in chronic liver disease.

Authors:  Anna Del Prete; Antonella Scalera; Maddalena Diana Iadevaia; Agnese Miranda; Claudio Zulli; Laura Gaeta; Concetta Tuccillo; Alessandro Federico; Carmelina Loguercio
Journal:  Evid Based Complement Alternat Med       Date:  2012-09-06       Impact factor: 2.629

4.  The role of curcumin in liver diseases.

Authors:  Antonio Riccardo Buonomo; Riccardo Scotto; Salvatore Nappa; Michele Arcopinto; Andrea Salzano; Alberto Maria Marra; Roberta D'Assante; Emanuela Zappulo; Guglielmo Borgia; Ivan Gentile
Journal:  Arch Med Sci       Date:  2018-02-20       Impact factor: 3.318

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.